Metastatic Colon Cancer Terminated Phase 2 Trials for Gefitinib (DB00317)

Also known as: Colon cancer stage IV / Colon cancer metastatic / Stage IV Colon Cancer / Malignant neoplasm of colon stage IV / Colon cancer Dukes D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00052585Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTreatment